Neochem Bio Solutions Limited (NSE:NEOCHEM)
India · Delayed Price · Currency is INR 91.35
+1.90 (2.12%)
At close: Jul 28, 2026
Neochem Bio Solutions Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,107 | 1,107 | 841.73 | 612.6 | 481.88 | 495.72 |
Revenue Growth | 129.72% | 31.51% | 37.40% | 27.13% | -2.79% | - |
Gross Profit Gross Profit Growth | 343.36 | 343.36 | 271.32 | 218.24 | 153.07 | 495.72 |
Operating Income Operating Income Growth | 213.07 | 213.07 | 135.43 | 57.21 | 35.42 | 12.6 |
Net Income Net Income Growth | 120.27 | 120.27 | 77.51 | 19.27 | 10.73 | 9.67 |
Earnings Per Share EPS Growth | 8.71 | 8.71 | 6.64 | 2.89 | 2.03 | - |
EPS Growth | 329.51% | 31.27% | 129.83% | 42.36% | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 769.29 | 552.36 | 419.79 | 44,347 |
Australia Australia Growth | 12.2 | - | - | - |
Bangladesh Bangladesh Growth | 14.63 | - | 32.74 | - |
Egypt Egypt Growth | 9.95 | - | - | - |
Indonesia Indonesia Growth | 7.38 | - | - | - |
Singapore Singapore Growth | 4.84 | - | 2.19 | - |
Uzbekistan Uzbekistan Growth | 3.43 | - | - | - |
Vietnam Vietnam Growth | 13.55 | - | 0.43 | - |
Thailand Thailand Growth | 6.45 | - | - | - |
Total Total Growth | 841.73 | 611.46 | 457.06 | 48,595 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1.81 | 1.81 | 0.55 | 3.51 | 0.48 | - |
Total Debt Total Debt Growth | 177.94 | 177.94 | 356.24 | 333.23 | 262.37 | - |
Net Cash (Debt) Net Cash Growth | -176.13 | -176.13 | -355.69 | -329.72 | -261.89 | - |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -12.76 | -12.76 | -30.45 | -49.40 | -49.50 | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -190.63 | -190.63 | 25.95 | -6.31 | -7.42 | - |
Capital Expenditures CapEx Growth | -25.46 | -25.46 | -11.41 | -83.85 | -33.3 | - |
Free Cash Flow Free Cash Flow Growth | -216.08 | -216.08 | 14.54 | -90.16 | -40.72 | - |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 31.02% | 31.02% | 32.23% | 35.63% | 31.76% | 100.00% |
Operating Margin | 19.25% | 19.25% | 16.09% | 9.34% | 7.35% | 2.54% |
Pretax Margin | 15.52% | 15.52% | 12.19% | 4.57% | 3.15% | 2.58% |
Profit Margin | 10.86% | 10.86% | 9.21% | 3.15% | 2.23% | 1.95% |
FCF Margin | -19.52% | -19.52% | 1.73% | -14.72% | -8.45% | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 10.49 | 9.00 | - | - | - | - |
PS Ratio | 1.41 | 0.98 | - | - | - | - |